Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Lantheus Medical Imaging |
---|---|
Information provided by: | Lantheus Medical Imaging |
ClinicalTrials.gov Identifier: | NCT00707538 |
The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158
Condition | Intervention | Phase |
---|---|---|
Healthy Volunteers |
Drug: BMS747158 |
Phase I |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Single Group Assignment |
Official Title: | A Phase I Dosimetry, Biodistribution and Safety Study of BMS747158 in Healthy Subjects Undergoing 2-Day Rest/Stress Positron Emission Tomography |
Estimated Enrollment: | 12 |
Study Start Date: | June 2008 |
Study Completion Date: | October 2008 |
Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Drug: BMS747158
2 IV injection of ~11 mCi (total) F-18 labeled compound
|
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
UCLA Medical Center | |
Los Angeles, California, United States, 90095 | |
United States, Maryland | |
John Hopkins University | |
Baltimore, Maryland, United States, 21287 |
Principal Investigator: | Jamshid Maddahi, MD | University of California, Los Angeles |
Responsible Party: | Lantheus Medical Imaging ( Qi Zhu, MD, MPH ) |
Study ID Numbers: | BMS-747158-102 |
Study First Received: | June 27, 2008 |
Last Updated: | December 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00707538 |
Health Authority: | United States: Food and Drug Administration |
Stress Healthy |